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Background
There have been multiple reports of young people being
diagnosed with severe lung disease with the common
link of recent electronic cigarette (E-cigarette) use. The
disease is described as a patient having acute respiratory
disease with no apparent infectious cause and
significant findings on lung imaging. It is also known as
Vaping Associated Lung Injury (VALI).
Reports reveal a surge of cases based in the Midwest,
but the CDC also reports outbreaks across the country.
Imaging of the disease commonly shows diffuse ground-
glass appearance with pan-injury, but there are still
many inconsistencies in the reported cases making it
difficult for definitive action to be taken by the FDA and
health officials.
Case Presentation
History of present illness:
• A 16-year old female with 5 days of shortness of breath
and constitutional symptoms was admitted from the ER
after failed outpatient treatment of pneumonia.
• She used tobacco e-cigarettes regularly and recently
used THC oil from an illicit dealer in her e-cigarette.
• Initial imaging demonstrated bilateral lower lobe
pneumonia, and labs were significant for leukocytosis,
elevated inflammatory markers, and a negative
Respiratory Panel PCR.
Hospital Course:
• The Patient’s respiratory status rapidly declined despite
aggressive pulmonary toileting therapies and broad-
spectrum antibiotics. By day 2 of admission, repeat
imaging showed worsening pneumonia with pulmonary
edema and pleural effusions (a and b). She required transfer
to the pediatric intensive care unit for non-invasive
positive pressure ventilation and eventually was
intubated and placed on mechanical ventilation.
• A chest CT scan was significant for diffuse bilateral
ground glass and interstitial infiltrates with air
bronchograms (c and d). She was started on high dose
steroids in addition to her antimicrobial therapy for
concern of chemical pneumonitis. Due to worsening
oxygen requirement and concern of ARDS-like illness
with air leak, she was transitioned to high frequency
oscillatory ventilation and was also treated with inhaled
nitric oxide for pulmonary hypertension.
• During her stay, pediatric infectious disease and
pediatric pulmonary physicians were consulted. She had
an extensive infectious work up including bronchoscopy
and multiple bacterial, viral, and fungal tests-- all results
were negative.
Outcome:
• The patient eventually weaned from her respiratory
support and recovered over several weeks, but no
infectious cause was ever determined.
The number of VALI cases are on the rise daily. Many
cases reported involve a history of THC use in the
devices, and most of the samples being tested by the
state and the FDA are being identified as containing
THC 6. However, at least ¼ of cases do not. This has
caused much distress to government agencies not
being able to take definitive action to help stay the
public health crisis. This puts a great strain on the
healthcare system and its resources. Quick action
needs to be taken by scientists, investigators, law
makers, public health officials and tobacco industry to
better understand both long-term and short-term
consequences of increased popularity of vaping in the
US.
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Discussion
In electronic cigarettes, the fluid filled cartridges that are heated by the device are often flavored with fruits such as
watermelon, cherry, mango (etc), which are likely appealing to youth. These flavors, that may unintentionally target younger
users are not harmless, and some research has shown damaging effects due to components that derive the flavoring.
According to one study, the measured amounts of benzaldehyde in flavored nicotine solutions used in e-cigarettes were
significantly higher in concentrations of cherry flavored solutions 1. Furthermore, approximately ¾ of reported cases were
linked to recent THC use in the device.
Among patients whom have been diagnosed with VALI, as many as 86% report using THC-Containing products; exclusive use
of THC-containing products are reported by 34% of patients according to the CDC 2. Among the various formulations of
cannabis, concentrates are seemingly problematic for adolescent population 3. 72% of high school students surveyed use
concentrated formulation of THC products 4. Even with most VALI cases being linked to THC containing products, there is no
specific pattern of pathology identified. All cases of confirmed VALI demonstrate histopathological findings with patterns
consistent with acute lung injury, acute fibrinous pneumonitis, diffuse alveolar damage, or organizing pneumonia– Similar to
findings in figure C. and D. 5
